Post-operative nausea and vomiting (PONV) is a common and often debilitating side-effect of surgery. It can be distressing for patients and can lead to longer hospital stays and increased costs. Fortunately, there are a number of innovative solutions available to help doctors overcome PONV and reduce its impact on their patients. In this article, we will take a look at the causes of PONV and explore some of the innovative solutions that doctors can use to reduce its incidence and impact.
Post-operative nausea and vomiting (PONV) is a common side-effect of surgery that can occur in up to 30% of patients. It is caused by the release of inflammatory mediators in the body in response to the trauma of surgery. It is characterized by nausea, vomiting, abdominal pain, and malaise. PONV can be distressing for patients and can lead to longer hospital stays and increased costs.
There are a number of factors that can increase the risk of PONV. These include the type of surgery, the type of anesthesia used, the patient’s age, gender, and medical history, the duration of the surgery, and the presence of other risk factors such as nausea and vomiting prior to surgery.
There are a number of strategies that doctors can use to reduce the risk of PONV. These include pre-operative antiemetic medications, the use of prophylactic antiemetics, and the avoidance of certain drugs and anesthetics that can increase the risk of PONV.
In addition to the traditional methods of preventing and treating PONV, there are a number of innovative solutions that doctors can use to reduce its incidence and impact. These include the use of virtual reality (VR) and augmented reality (AR) technology, the use of wearable devices, and the use of artificial intelligence (AI) to identify patients at risk of PONV.
Virtual reality (VR) and augmented reality (AR) technology can be used to create immersive, 3D environments that can help to distract patients from the nausea and vomiting associated with PONV. This can help to reduce the severity of the symptoms and can also help to reduce the need for antiemetic medications.
Wearable devices such as smartwatches and fitness trackers can be used to monitor patients for signs of PONV. These devices can detect changes in heart rate, temperature, and other vital signs that may indicate the onset of PONV. By monitoring these changes in real-time, doctors can intervene early and reduce the severity of the symptoms.
Artificial intelligence (AI) can be used to identify patients who are at risk of developing PONV. By analyzing a patient's medical history, demographics, and other factors, AI can identify patients who are likely to experience PONV and can alert doctors to intervene early.
Post-operative nausea and vomiting (PONV) is a common and often debilitating side-effect of surgery. Fortunately, there are a number of innovative solutions available to help doctors reduce its incidence and impact. These include the use of virtual reality (VR) and augmented reality (AR) technology, the use of wearable devices, and the use of artificial intelligence (AI) to identify patients at risk of PONV. By using these innovative solutions, doctors can help to reduce the severity of PONV and improve the quality of care for their patients.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation